The Medlior team has produced several publications as authors and acknowledged medical writers for conference abstracts/posters, environmental scan reports and journal publications.

2017 Publications

2016 Publications

2015 Publications

Medical Writing

  • Huanzue Zhou, Christopher Taber, Steve Arcona and Yunfeng Li. Difference-in-Difference Method in Comparative Effectiveness Research: Utility with Unbalanced Groups. Appl Health Econ Health Policy. 2016, 14: 419-429

  • Jacqueline B. Palmer, Yunfeng Li, Vivian Herrera, Minlei Liao, Melody Tran and Zafer E. Ozturk. Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis. BMC Musculoskeletal Disorders. 2016, 17:261

  • Vegesna Ashok, Tran Melody, Angelaccio Michele, and Arcona Steve. Review: Remote Patient Monitoring via Non-Invasive Digital Technologies: A Systematic Review. Telemedicine and e-Health. April 2016, ahead of print. doi:10.1089/tmj.2016.0051.
  • Fine S., Poulin-Costello M., Barron R., Mittmann N. The use of Granulocyte Colony Stimulating Factors in the Canadian Outpatient Setting. Curr Oncol. 2014; 21 (e229-240)
  • Swindle J, Xe X, Mallick R, Song R, Horstman T, Bays HE. Colesevelam, Ezetimibe, and Patients with Type 2 Diabetes Mellitus: Characteristics and Clinical Outcomes from a Health Care Database. Annals of Pharmacotherapy 2014; 1 –9 (e-pub)
  • Johnson P., Barron R., Legg J., Li X., Watson H., Marshall DA. Discrete Choice Experiment to Estimate Breast Cancer Patients’ Preferences and Willingness-to-Pay for Prophylactic Granulocyte Colony-Stimulating Factors. Value in Health. 17(4):380-9. 2014 June.
  • Teitelbaum A, Ba-Mancini A, Huang H, Henk HJ. Health care costs and resource utilization, including patient burden, associated with novel-agent-based treatment versus other therapies for multiple myeloma: findings using real-world claims data. The oncologist 2013; 18(1): 37-45.